14-104774967-G-A

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_001382430.1(AKT1):​c.604C>T​(p.Leu202Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00698 in 1,612,822 control chromosomes in the GnomAD database, including 676 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. L202L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.036 ( 337 hom., cov: 33)
Exomes 𝑓: 0.0040 ( 339 hom. )

Consequence

AKT1
NM_001382430.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 3.04

Publications

8 publications found
Variant links:
Genes affected
AKT1 (HGNC:391): (AKT serine/threonine kinase 1) This gene encodes one of the three members of the human AKT serine-threonine protein kinase family which are often referred to as protein kinase B alpha, beta, and gamma. These highly similar AKT proteins all have an N-terminal pleckstrin homology domain, a serine/threonine-specific kinase domain and a C-terminal regulatory domain. These proteins are phosphorylated by phosphoinositide 3-kinase (PI3K). AKT/PI3K forms a key component of many signalling pathways that involve the binding of membrane-bound ligands such as receptor tyrosine kinases, G-protein coupled receptors, and integrin-linked kinase. These AKT proteins therefore regulate a wide variety of cellular functions including cell proliferation, survival, metabolism, and angiogenesis in both normal and malignant cells. AKT proteins are recruited to the cell membrane by phosphatidylinositol 3,4,5-trisphosphate (PIP3) after phosphorylation of phosphatidylinositol 4,5-bisphosphate (PIP2) by PI3K. Subsequent phosphorylation of both threonine residue 308 and serine residue 473 is required for full activation of the AKT1 protein encoded by this gene. Phosphorylation of additional residues also occurs, for example, in response to insulin growth factor-1 and epidermal growth factor. Protein phosphatases act as negative regulators of AKT proteins by dephosphorylating AKT or PIP3. The PI3K/AKT signalling pathway is crucial for tumor cell survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating AKT1 which then phosphorylates and inactivates components of the apoptotic machinery. AKT proteins also participate in the mammalian target of rapamycin (mTOR) signalling pathway which controls the assembly of the eukaryotic translation initiation factor 4F (eIF4E) complex and this pathway, in addition to responding to extracellular signals from growth factors and cytokines, is disregulated in many cancers. Mutations in this gene are associated with multiple types of cancer and excessive tissue growth including Proteus syndrome and Cowden syndrome 6, and breast, colorectal, and ovarian cancers. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2020]
AKT1 Gene-Disease associations (from GenCC):
  • Proteus syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Cowden disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Cowden syndrome 6
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 14-104774967-G-A is Benign according to our data. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-104774967-G-A is described in CliVar as Benign. Clinvar id is 416469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.122 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AKT1NM_001382430.1 linkc.604C>T p.Leu202Leu synonymous_variant Exon 8 of 15 ENST00000649815.2 NP_001369359.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AKT1ENST00000649815.2 linkc.604C>T p.Leu202Leu synonymous_variant Exon 8 of 15 NM_001382430.1 ENSP00000497822.1 P31749-1

Frequencies

GnomAD3 genomes
AF:
0.0359
AC:
5461
AN:
151982
Hom.:
337
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.125
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0123
Gnomad ASJ
AF:
0.000577
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000831
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000603
Gnomad OTH
AF:
0.0263
GnomAD2 exomes
AF:
0.00969
AC:
2425
AN:
250248
AF XY:
0.00707
show subpopulations
Gnomad AFR exome
AF:
0.127
Gnomad AMR exome
AF:
0.00666
Gnomad ASJ exome
AF:
0.000598
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000330
Gnomad NFE exome
AF:
0.000637
Gnomad OTH exome
AF:
0.00540
GnomAD4 exome
AF:
0.00396
AC:
5791
AN:
1460722
Hom.:
339
Cov.:
31
AF XY:
0.00346
AC XY:
2513
AN XY:
726678
show subpopulations
African (AFR)
AF:
0.132
AC:
4407
AN:
33476
American (AMR)
AF:
0.00770
AC:
344
AN:
44678
Ashkenazi Jewish (ASJ)
AF:
0.000689
AC:
18
AN:
26118
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.000302
AC:
26
AN:
86232
European-Finnish (FIN)
AF:
0.000247
AC:
13
AN:
52626
Middle Eastern (MID)
AF:
0.0118
AC:
67
AN:
5682
European-Non Finnish (NFE)
AF:
0.000342
AC:
380
AN:
1111852
Other (OTH)
AF:
0.00886
AC:
535
AN:
60358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
292
584
875
1167
1459
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
144
288
432
576
720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0359
AC:
5463
AN:
152100
Hom.:
337
Cov.:
33
AF XY:
0.0340
AC XY:
2531
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.125
AC:
5169
AN:
41424
American (AMR)
AF:
0.0123
AC:
188
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.000577
AC:
2
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.000832
AC:
4
AN:
4810
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10616
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000603
AC:
41
AN:
67994
Other (OTH)
AF:
0.0261
AC:
55
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
245
490
734
979
1224
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0167
Hom.:
87
Bravo
AF:
0.0413
Asia WGS
AF:
0.00635
AC:
22
AN:
3478
EpiCase
AF:
0.000818
EpiControl
AF:
0.000831

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Cowden syndrome 6 Benign:2
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Apr 03, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.60
CADD
Benign
17
DANN
Benign
0.75
PhyloP100
3.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.25
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.25
Position offset: -6

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2230506; hg19: chr14-105241304; COSMIC: COSV104422011; API